Trends in Mesh Use for Pelvic Organ Prolapse Repair From the Medicare Database

Wang, Lily C.; Awamlh, Bashir Al Hussein Al; Hu, Jim C.; Laudano, Melissa; Davison, Wesley; Schulster, Michael; Zhao, Fu-Jun; Chughtai, Bilal; Lee, Richard K.

doi:10.1016/j.urology.2015.08.022

Cited by 47 publications

(26 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Around the years 2009 and 2010, an important decrease was reported, explained as a direct result of the FDA public health notification issued in October 2008 . A second FDA notification was launched in 2011, emphasizing the complications associated with the use of transvaginal mesh in POP repair and inducing a chain reaction from patients, physicians, manufacturers, and lawyers . On the contrary, abdominal sacrocolpopexy was replaced by laparoscopic and robotic‐assisted approaches, with a dramatic increase of the latter between 2007 and 2010 .…”

Section: Discussionmentioning

confidence: 99%

“…This resulted on massive media attention and the proliferation of legal activity directed at mesh products, which motivated several manufacturers to voluntarily withdraw their product from the market, reducing mesh use in the United States . This situation was followed by an introduction of new technologies and a renewed interest in traditional procedures . In contrast, European countries have reported an increase in the use of surgical mesh for POP repair in recent years, even though the Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) launched a recommendation in 2015 stating that “the implantation of any mesh for the treatment of POP via the vaginal route should only be considered in complex cases, in particular, after failed primary repair surgery.” The impact of such events in LATAM has not been assessed.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Trends in pelvic organ prolapse management in Latin America

Plata

Bravo‐Balado

Robledo

et al. 2017

Neurourology and Urodynamics

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Trends in pelvic organ prolapse management in Latin America

Plata

Bravo‐Balado

Robledo

et al. 2017

Neurourology and Urodynamics

View full text Add to dashboard Cite

show abstract

“…Rates of minimally invasive sacrocolpopexy have increased substantially for the past decade. 11–13 Using 2001–2011 Medicare claims data, Wang et al 13 found that the annual volume of sacrocolpopexy averaged 100 to 180 cases per year from 2004 to 2007. This increased to 1720 cases in 2011.…”

Section: Discussionmentioning

confidence: 99%

One-Year Outcomes After Minimally Invasive Sacrocolpopexy

Kenton¹,

Mueller²,

Tarney³

et al. 2016

Female Pelvic Med Reconstr Surg

View full text Add to dashboard Cite

Objective The primary aim of this study was to report anatomic, symptom, and quality of life outcomes in women with symptomatic stage 2 or greater prolapse 1 year after randomization to robotic and laparoscopic sacrocolpopexy. Methods This is a planned ancillary analysis of the Abdominal Colpopexy: Comparison of Endoscopic Surgical Strategies trial, a randomized comparative effectiveness trial comparing costs and outcomes of robotic and laparoscopic sacrocolpopexy at 2 academic medical centers. At baseline and 1 year after surgery, women underwent standardized assessment including validated subjective pelvic floor outcomes and physical examination with prolapse assessment. Results Sixty six (85%) of 78 randomized participants completed 1-year follow-up: 33 (87%) of 38 in the laparoscopic arm and 33 (83%) of 40 in the robotic arm (P = 0.59). Ninety-seven percent (32/33) in the laparoscopic group and 100% (33/33) in the robotic arm considered that their prolapse symptoms improved (P = 0.999). The cohort had significant improvement in all pelvic floor symptom and quality of life measures, which did not differ by treatment arm. Of women who were sexually active at 1 year, sexual function improved in both cohorts. No new serious adverse events, including mesh exposure or reoperation for prolapse, were identified between 6 months and 1 year after surgery. No women had a sacrocolpopexy mesh complication or reoperation for mesh exposure. Conclusions Minimally invasive sacrocolpopexy is associated with significant improvement in pelvic floor symptoms, anatomy, and sexual function. In addition, mesh exposure rates with lightweight polypropylene mesh seem to be lower than those reported with multifilament and heavier polypropylene mesh.

show abstract

“…A hüvelyi hálóműtétek száma 2005 és 2008 között hihetetlen mértékben, a 16,5-szeresére − 2%-ról 35%-raemelkedett. Ezzel párhuzamosan egyre több tapasztalat gyűlt össze ezek szövődményeiről [15]. A hálóműtétek relatíve alacsony kiújulás mellett (2-4,8%) [8,14] viszonylag magas szövődményrátával bírtak.…”

Section: A Hálóműtétek Szövődményeiunclassified